Previously, we reported that T98G cells derived from a human GBM contain a functional clock that regulates metabolic oscillations and temporal susceptibility to Bortezomib administration (proteasome inhibitor) (Wagner et al. 2018). Here, CLOCK is linked to glioblastoma.